Clinical trial
Genetic Risk Score of Type 1 Diabetes Mellitus for Progression to Insulin in Diabetic Patients Lack of Predictive Value: a Multicenter Nested Case-control Study
NCT07621445 is registered in ClinicalTrials.gov with Second Xiangya Hospital of Central South University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Genetic Risk Score of Type 1 Diabetes Mellitus for Progression to Insulin in Diabetic Patients Lack of Predictive Value: a Multicenter Nested Case-control Study
- Lead sponsor
- Second Xiangya Hospital of Central South University
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- October 27, 2025
- Completion date
- December 31, 2029
- Enrollment
- 2,950 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.